
### [NCIT:C3796](http://purl.obolibrary.org/obo/NCIT_C3796)
**Label:** Gliosarcoma

**Subclasses:** [NCIT:C9370](http://purl.obolibrary.org/obo/NCIT_C9370) (Adult Brain Stem Gliosarcoma), [NCIT:C68701](http://purl.obolibrary.org/obo/NCIT_C68701) (Adult Gliosarcoma), [NCIT:C115365](http://purl.obolibrary.org/obo/NCIT_C115365) (Recurrent Childhood Gliosarcoma), [NCIT:C131209](http://purl.obolibrary.org/obo/NCIT_C131209) (Recurrent Gliosarcoma), [NCIT:C114759](http://purl.obolibrary.org/obo/NCIT_C114759) (Childhood Brain Stem Gliosarcoma), [NCIT:C114968](http://purl.obolibrary.org/obo/NCIT_C114968) (Childhood Gliosarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification) 57.14%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 57.14%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 57.14%
- Thing 52.15%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 42.50%
- [NCIT:C41471](http://purl.obolibrary.org/obo/NCIT_C41471) (Glial Differentiation) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 42.50%


